Active — Not RecruitingPhase 1/2

Spinal Cord Neuromodulation for Spinal Cord Injury

United States12 participantsStarted 2013-07

Plain-language summary

This study is designed to assess the strategy of using spinal cord stimulation to improve the ability to move in spinal cord injured humans.

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Stable medical condition without cardiopulmonary disease or dysautonomia that would contraindicate hand/arm movement
✓. No severe cardiopulmonary diseases such as severe bradycardia, severe autonomic dysreflexia, and/or Chronic Obstructive Pulmonary Disease.
✓. No painful musculoskeletal dysfunction, unhealed fracture, contracture, pressure sore, or infection that might interfere with upper extremity training
✓. No clinically significant depression or ongoing drug abuse
✓. No current anti-spasticity medication regimen
✓. Non-progressive SCI above C5
✓. Must not have received botox injections in the prior six months
✓. Be unable to grip or move independently

Assessment of arm/hand function

Timeframe: 24 months

NCT IDNCT02313194

SponsorUniversity of California, Los Angeles

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-30